Clinical Trial Update: Comparison Between XELOX and S1, Oxaliplatin and Docetaxel as Neoadjuvant Chemotherapy for Gastric Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial comparing XELOX (capecitabine + oxaliplatin) versus S-1 with oxaliplatin and docetaxel as neoadjuvant chemotherapy for gastric cancer; th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• Capecitabine (capecitabine)
• DOCETAXEL (DOCETAXEL)
• OXALIPLATIN (Oxaliplatin)
• S-1 (tegafur/gimeracil/oteracil)

Snippet

Sponsor: Tianshu Liu | Conditions: Gastric Cancer | Phase 2 | Status: UNKNOWN